Drug abuse testing is used to detect illicit drug usage, including cases when people drive under the influence. It is also used to determine the sort of illegal material consumed, monitor patients in rehabilitation, and detect performance-enhancing drugs in sports. Furthermore, drug testing is critical in detecting prospective victims of substance misuse and lowering the morbidity and mortality associated with drug use. These tests can detect even low levels of drugs without interference from other chemicals.
Various countries have developed legal rules and clinical recommendations to guarantee that drug misuse testing is used effectively for medical and legal purposes. It is increasingly being used by business and public enterprises, government agencies, and healthcare providers. This market's growth is primarily driven by the increasing use of drug abuse testing in organizations, as well as the global production and sale of illegal drugs. Furthermore, the spike in traffic accident mortality and the increasing usage of illicit narcotics are contributing to market expansion.
Download Sample Report Copy https://www.acumenresearchandconsulting.com/request-sample/384
The increased manufacture and trafficking of illegal drugs around the world has created an increasing demand for drug misuse testing. According to UN figures, excessive drug use kills roughly 200,000 individuals each year. Furthermore, the National Highway Traffic Safety Administration reports that 13,524 individuals were died in preventable crashes in 2022. In reality, during the 10-year period from 2013 to 2022, approximately 11,000 people died in drunk-driving crashes. Expanding the use of drug abuse testing by individuals, parents, and law enforcement organizations can help reduce such events and promote public safety.
The drug misuse testing industry has grown steadily in recent years, owing to a number of major factors. One key aspect is the increasing frequency of drug usage around the world, particularly in the United States. The opioid crisis, in particular, has increased demand for drug testing, as healthcare practitioners and businesses seek to detect and support people who are at risk of addiction or overdose. Another factor driving market growth is the increased availability of drug testing goods and services. A variety of testing alternatives are now available, including urine, blood, and hair tests, as well as sophisticated technologies for identifying substances in saliva and sweat. Furthermore, the growth of companies providing drug testing services has increased accessibility and affordability, making drug testing more broadly available to both organizations and people.
The global market for drug of abuse testing has been segmented into drug type, product, sample type, end user, and region.
In terms of drug of abuse testing market analysis, in 2024, North America dominated the global drug abuse testing market, with a market share of more than 39%. This expansion was primarily driven by increased drug availability, an increase in occupational drug testing, and a boom in drug trafficking throughout the area.
However, the Asia-Pacific area is predicted to rise significantly throughout the forecast period, driven by rising illegal drug and alcohol usage, as well as strong government policies enforcing alcohol testing.
Drug of abuse testing companies profiled in the report include Quest Diagnostics, Inc, DrugScan, Legacy Medical Services, Mayo Clinic Laboratories, Precision Diagnostics, Cordant Health Solutions, Danaher Corporation, LGC Group, LabCorp, and Abbott Laboratories.
Buy Now This Report :https://www.acumenresearchandconsulting.com/buy-now/0/384
Parameter |
Details |
Size in 2024 |
USD 7.05 Billion |
Forecast by 2033 |
USD 12.46 Billion |
CAGR During 2025 - 2033 |
6.7% |
Largest Drug Type Segment (% share 2024) |
Marijuana/Cannabis– 28% |
Largest Region Size (2024) |
North America - USD 2.75 Billion |
Fastest Growing Region (% CAGR) |
Asia-Pacific– 7.3% |
Key Players Covered |
Quest Diagnostics, Inc, DrugScan, Legacy Medical Services, Mayo Clinic Laboratories, Precision Diagnostics, Cordant Health Solutions, Danaher Corporatio, LGC Group, LabCorp, and Abbott Laboratories. |
Request Customization |
Mr. Richard Johnson
Acumen Research and Consulting
India: +91 8983225533